These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18158644)

  • 1. Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.
    How OJ; Larsen TS; Hafstad AD; Khalid A; Myhre ES; Murray AJ; Boardman NT; Cole M; Clarke K; Severson DL; Aasum E
    Arch Physiol Biochem; 2007; 113(4-5):211-20. PubMed ID: 18158644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice.
    How OJ; Aasum E; Severson DL; Chan WY; Essop MF; Larsen TS
    Diabetes; 2006 Feb; 55(2):466-73. PubMed ID: 16443782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice.
    Boardman N; Hafstad AD; Larsen TS; Severson DL; Aasum E
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1373-9. PubMed ID: 19286944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
    Hafstad AD; Khalid AM; How OJ; Larsen TS; Aasum E
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.
    Aasum E; Hafstad AD; Severson DL; Larsen TS
    Diabetes; 2003 Feb; 52(2):434-41. PubMed ID: 12540618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic and acute exposure of mouse hearts to fatty acids increases oxygen cost of excitation-contraction coupling.
    Boardman NT; Larsen TS; Severson DL; Essop MF; Aasum E
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1631-6. PubMed ID: 21335471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
    Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired cytosolic NADH shuttling and elevated UCP3 contribute to inefficient citric acid cycle flux support of postischemic cardiac work in diabetic hearts.
    Banke NH; Lewandowski ED
    J Mol Cell Cardiol; 2015 Feb; 79():13-20. PubMed ID: 25450611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
    Hafstad AD; Khalid AM; Hagve M; Lund T; Larsen TS; Severson DL; Clarke K; Berge RK; Aasum E
    Cardiovasc Res; 2009 Aug; 83(3):519-26. PubMed ID: 19398469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E; Cooper M; Severson DL; Larsen TS
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury.
    Yue TL; Bao W; Gu JL; Cui J; Tao L; Ma XL; Ohlstein EH; Jucker BM
    Diabetes; 2005 Feb; 54(2):554-62. PubMed ID: 15677515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3.
    Bugger H; Boudina S; Hu XX; Tuinei J; Zaha VG; Theobald HA; Yun UJ; McQueen AP; Wayment B; Litwin SE; Abel ED
    Diabetes; 2008 Nov; 57(11):2924-32. PubMed ID: 18678617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.
    Belke DD; Larsen TS; Gibbs EM; Severson DL
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1104-13. PubMed ID: 11052966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.
    He H; Tao H; Xiong H; Duan SZ; McGowan FX; Mortensen RM; Balschi JA
    Toxicol Sci; 2014 Apr; 138(2):468-81. PubMed ID: 24449420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury.
    Khandoudi N; Delerive P; Berrebi-Bertrand I; Buckingham RE; Staels B; Bril A
    Diabetes; 2002 May; 51(5):1507-14. PubMed ID: 11978649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts.
    How OJ; Aasum E; Kunnathu S; Severson DL; Myhre ES; Larsen TS
    Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2979-85. PubMed ID: 15764683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
    Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
    Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.
    Wölkart G; Schrammel A; Dörffel K; Haemmerle G; Zechner R; Mayer B
    Br J Pharmacol; 2012 Jan; 165(2):380-9. PubMed ID: 21585347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.
    Sidell RJ; Cole MA; Draper NJ; Desrois M; Buckingham RE; Clarke K
    Diabetes; 2002 Apr; 51(4):1110-7. PubMed ID: 11916933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.